Clinical Trial: Efficacy and Safety of Adding All-Trans Retinoic Acid to Azacitidine Plus Venetoclax in Newly Diagnosed Adult Patients with Non-APL Acute Myeloid Leukemia (China)

China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Adding All-Trans Retinoic Acid to Azacitidine Plus Venetoclax in Newly Diagnosed Adult Patients with Non-APL Acute Myeloid Leukemia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133199

Registration Time: 2026/09/22

Type: Observational study

Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343806

Published by HT Digital Content Services with permission from Health Daily Digest....